Home › Amyloid Plaque
Amyloid Plaque clinical trials recruiting in the U.S.
10 studies for Amyloid Plaque are recruiting participants at sites across the United States.
By state
Recently updated studies
Oil Pulling Reduction
Recruiting
Ages 18 to 70 · All sexes · Updated Aug 24, 2026 · NCT07706647A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Aug 20, 2026 · NCT06659549Sleep Trial to Prevent Alzheimer's Disease
RecruitingPhase 2Healthy volunteers welcome
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT04629547A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
RecruitingPhase 1/2
Ages 35 to 85 · All sexes · Updated Jul 10, 2026 · NCT05462106A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
RecruitingPhase 3
Ages 55 and older · All sexes · Updated Jul 7, 2026 · NCT07602582Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 8, 2026 · NCT04579120Assessing the Influence of Habitual Beef Intake on Key Molecular Markers of Brain Health
RecruitingHealthy volunteers welcome
Ages 65 and older · All sexes · Updated Jun 3, 2026 · NCT07623785Clinical Study to Collect and Analyze Dental Plaque and Oral Health Measures in a Population With High Plaque/Low Gingivitis and High Plaque/High Gingivitis
RecruitingPhase 4
Ages 18 and older · All sexes · Updated May 29, 2026 · NCT07614490Comparison of the Effects of Oral Hygiene Regimens on Clinical, Immunomodulatory, and Microbial Outcomes and Oral Tolerance in People With Gingivitis
RecruitingHealthy volunteers welcome
Ages 18 to 60 · All sexes · Updated Mar 30, 2026 · NCT07501455Digital vs. Parent Modeled Toothbrushing
RecruitingHealthy volunteers welcome
Ages 3 to 6 · All sexes · Updated Feb 27, 2026 · NCT07441148From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.